美國Cancer Genetics, Inc. (CGI)
癌癥遺傳學公司(CGI)是一個個性化的醫藥等新興的領導者,產品和服務,使癌癥診斷和治療是針對具體個人的遺傳特征。成立于1999年由世界知名Dr. R.S.K. Chaganti博士.產品正在共同閘道介面發展將轉變癌癥患者管理,提高治療效果,并減少醫療費用。共同閘道介面的先進的測試結果,以及最先進的參考實驗室國家提供基因組信息,病人和他們的醫生最需要的 - 診斷,監測和通報癌癥治療。
An Emerging Leader In Cancer Diagnostics
Cancer Genetics, Inc. (CGI) is an emerging leader in personalized medicine, with products and services that enable cancer diagnostics and treatment that are tailored to the specific genetic profile of the individual.
Products being developed at CGI are poised to transform cancer patient management, increase treatment efficacy, and reduce healthcare costs. CGI’s cutting-edge proprietary tests and state of the art reference lab provide genomic information where patients and their physicians need it most – to diagnose, monitor and inform cancer treatment.
Founded in 1999 by world-renowned cytogeneticist Dr. R.S.K. Chaganti, CGI’s scientific advisory board includes leading specialists in clinical cytogenetics, as well as significant thought leaders capable of driving adoption in the tri-state area.
The company has been built on world-class scientific knowledge and IP in solid and blood-borne cancers, as well as strong academic relationships with major cancer centers such as Memorial Sloan-Kettering and the National Cancer Institute.